The absence of effective and high-throughput metastatic cell models in vitro has obstructed anti-metastatic drug discovery.
Animal models, in vitro studies, and mathematical models have all contributed to our understanding of drug-resistant strains.
Two-dimensional (2D) models (in vitro and in vivo) have inherent limitations with regard to controllability, reproducibility and flexibility of design (Khanna and Hunter 2005).
Importantly, our review also introduces a new concept of engineering artificial BM platforms for reconstituting BBB models in vitro.
This focused review discusses the importance and relevance of 3D printing technologies in building tumor models in vitro.
The authors compared human natural killer memory cells to non-memory control cells, then demonstrated their effectiveness against myeloid leukemia models in vitro and in mice.
Although the reconstruction of functional 3D liver tissue models in vitro presents numerous challenges, it is in great demand for drug development, regenerative medicine, and physiological studies.
They are useful models in vitro for investigation of mechanisms in morphogenesis and of cell lineage in differentiation, and for clinical application for tooth regeneration.
In light of this tunable drug-loading capability, these CT hydrogels would be highly attractive as drug reservoirs towards e.g. the fabrication of tissue models in vitro.
Their excellent activity for delivering different RNAi therapeutics in various disease models in vitro and in vivo will be highlighted here.
c RGDyK -pHA-PEG-DSPE-incorporated liposomes (c RGDyK -pHA-PEG-DSPE-incorporatedtrate the 3D glioma spheroids after c RGDyK -pHA-PEG-DSPE-incorporatedn vitro.
